Press Releases from DelveInsight Business Research (5349 total)
Achondroplasia Market Size 2034: EMA, PDMA, FDA Approval, Clinical Trials, Medic …
(Albany, USA) DelveInsight's "Achondroplasia Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Achondroplasia, historical and forecasted epidemiology as well as…
Obesity Market Size 2034: EMA, PDMA, FDA Approval, Clinical Trials, Medication, …
(Albany, USA) DelveInsight's "Obesity Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of obesity, historical and forecasted epidemiology as well…
Schizophrenia Market Size 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Treat …
(Albany, USA) DelveInsight's "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" report offers an in-depth understanding of Schizophrenia, including historical and forecasted epidemiology, as well as…
Dermatomyositis Treatment Market 2034: EMA, PDMA, FDA Approval, Clinical Trials, …
(Albany, USA) DelveInsight's "Dermatomyositis Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of Dermatomyositis, historical and forecasted epidemiology as well…
Diabetic Foot Ulcers Market to Expand Significantly by 2034, States DelveInsight …
The Diabetic Foot Ulcers market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage…
HPK1 Inhibitor Market Anticipated to Expand Rapidly During 2024-2034, Says Delve …
DelveInsight's "HPK1 Inhibitor Competitive Landscape And Market Forecast - 2034′′ report offers an in-depth understanding of the HPK1 Inhibitor, historical and forecasted epidemiology as well…
Crohn's Disease Market Expected to Experience Major Growth by 2034, According to …
The Crohn's Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Crohn's…
Non-Alcoholic Steatohepatitis Market Set to Grow Substantially Through 2034, Del …
DelveInsight's "Non-Alcoholic Steatohepatitis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Non-Alcoholic Steatohepatitis, historical and forecasted epidemiology as well as…
Spinal Cord Injury Market to Show Remarkable Growth Trends from 2024 to 2034, De …
DelveInsight's "Spinal Cord Injury Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Spinal Cord Injury, historical and forecasted epidemiology as…
ESR1 Mutated Metastatic Breast Cancer Market Predicted to See Upsurge Through 20 …
DelveInsight's "ESR1 Mutated Metastatic Breast Cancer Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the ESR1 Mutated Metastatic Breast Cancer, historical…
Myasthenia Gravis Market Growth to Accelerate in Forecast Period (2024-2034), De …
DelveInsight's "Myasthenia Gravis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Myasthenia Gravis, historical and forecasted epidemiology as well as…
Degenerative Disc Disease Pipeline 2025: Latest FDA Approvals, Clinical Trials, …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Degenerative Disc Disease pipeline constitutes 15+ key companies continuously working towards developing 15+ Degenerative…
HER2 Positive Breast Cancer Market to Witness Upsurge in Growth During the Forec …
The HER2 Positive Breast Cancer market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various…
Sensorineural Hearing Loss Pipeline 2025: Comprehensive Clinical Trials and Ther …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Sensorineural Hearing Loss pipeline constitutes 20+ key companies continuously working towards developing 21+ Sensorineural…
ER+/HER2- Breast Cancer Treatment Market 2034: EMA, PDMA, FDA Approval, Clinical …
(Albany, USA) DelveInsight has launched a new report on "ER+/HER2- Breast Cancer - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of…
Malignant Pleural Mesothelioma Clinical Trials 2025: EMA, PDMA, FDA Approvals, M …
(Albany, USA) Malignant Pleural Mesothelioma Pipeline constitutes 20+ key companies continuously working towards developing 20+ Malignant Pleural Mesothelioma treatment therapies, analyzes DelveInsight.
"Malignant Pleural Mesothelioma Pipeline…
C-Met Mutated Non-Small Cell Lung Cancer Clinical Trials 2025: EMA, PDMA, FDA Ap …
(Albany, USA) DelveInsight's, "C-Met Mutated Non-Small Cell Lung Cancer Pipeline Insight 2025" constitutes 5+ key companies continuously working towards developing 5+ C-Met Mutated Non-Small Cell…
Gastric Cancer Drugs Market 2034: EMA, PDMA, FDA Approvals, Clinical Trials, Med …
(Albany, USA) DelveInsight's "Gastric Cancer Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Gastric Cancer, historical and forecasted epidemiology as…
Chemotherapy Induced Neutropenia Drugs Market 2032: EMA, PDMA, FDA Approvals, Cl …
(Albany, USA) DelveInsight's "Chemotherapy Induced Neutropenia Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Chemotherapy Induced Neutropenia, historical and forecasted…
Leber's Hereditary Optic Neuropathy Treatment Market 2034: EMA, PDMA, FDA Approv …
(Albany, USA) DelveInsight's "Leber's Hereditary Optic Neuropathy Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Leber's Hereditary Optic Neuropathy, historical…
Krabbe Disease Treatment Market 2034: EMA, PDMA, FDA Approval, Clinical Trials, …
(Albany, USA) DelveInsight's "Krabbe Disease Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Krabbe Disease, historical and forecasted epidemiology as…
CDKL5 Deficiency Disorder Treatment Market 2034: EMA, PDMA, FDA Approval, Clinic …
(Albany, USA) DelveInsight's "CDKL5 Deficiency Disorder Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the CDKL5 Deficiency Disorder, historical and forecasted…
WHIM Syndrome Drugs Market 2034: EMA, PDMA, FDA Approval, Clinical Trials, Medic …
(Albany, USA) DelveInsight's "WHIM Syndrome Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the WHIM Syndrome, historical and forecasted epidemiology as…
Underactive Bladder Treatment Market 2034: EMA, PDMA, FDA Approvals, Clinical Tr …
(Albany, USA) DelveInsight's "Underactive Bladder Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Underactive Bladder, historical and forecasted epidemiology as…
KRAS Inhibitors Market Expected to Experience Major Growth by 2034, According to …
DelveInsight's "KRAS Inhibitors Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the KRAS Inhibitors, historical and forecasted epidemiology as well as…
Neuroendocrine Tumor Market Set to Grow Substantially Through 2034, DelveInsight …
The Neuroendocrine Tumor market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Neuroendocrine…
Pancreatic Cancer Market to Show Remarkable Growth Trends from 2024 to 2034, Del …
The Pancreatic Cancer market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage pipeline…
Antibody Drug Conjugates Market Predicted to See Upsurge Through 2034, Highlight …
DelveInsight's "Antibody Drug Conjugates Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Antibody Drug Conjugates, historical and forecasted epidemiology as…
Advanced Renal Cell Carcinoma Market Growth to Accelerate in Forecast Period (20 …
DelveInsight's "Advanced Renal Cell Carcinoma Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Antibody Drug Conjugates, historical and forecasted epidemiology…
HPV16+ Anogenital Cancers Treatment Market 2032: Clinical Trials, EMA, PDMA, FDA …
(Albany, USA) DelveInsight's "HPV16+ Anogenital Cancers Market Insights, Epidemiology, and Market Forecast-2032" Report delivers an in-depth understanding of the HPV16+ Anogenital Cancers, historical and forecasted…
Triple Refractory Multiple Myeloma Market Forecast 2032: Clinical Trials, EMA, P …
(Albany, USA) DelveInsight's "Triple Refractory Multiple Myeloma Market Insights, Epidemiology, and Market Forecast-2032" Report delivers an in-depth understanding of the Triple Refractory Multiple Myeloma, historical…
Pediatric Brain Tumors Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Ap …
(Albany, USA) DelveInsight's "Pediatric Brain Tumors Market Insights, Epidemiology, and Market Forecast-2034" Report delivers an in-depth understanding of the Pediatric Brain Tumors, historical and forecasted…
Upper Tract Urothelial Cancer Treatment Market 2032: Clinical Trials, EMA, PDMA, …
(Albany, USA) DelveInsight's "Upper Tract Urothelial Cancer Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Upper Tract Urothelial Cancer, historical…
Uterine leiomyosarcoma Treatment Market 2032: Clinical Trials, EMA, PDMA, FDA Ap …
(Albany, USA) DelveInsight's "Uterine leiomyosarcoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Uterine leiomyosarcoma, historical and forecasted epidemiology as…
KRAS Inhibitors Market Expected to Experience Major Growth by 2034, According to …
DelveInsight's "KRAS Inhibitors Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the KRAS Inhibitors, historical and forecasted epidemiology as well as…
Neuroendocrine Tumor Market Set to Grow Substantially Through 2034, DelveInsight …
The Neuroendocrine Tumor market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Neuroendocrine…
Pancreatic Cancer Market to Show Remarkable Growth Trends from 2024 to 2034, Del …
The Pancreatic Cancer market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage pipeline…
Antibody Drug Conjugates Market Predicted to See Upsurge Through 2034, Highlight …
DelveInsight's "Antibody Drug Conjugates Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Antibody Drug Conjugates, historical and forecasted epidemiology as…
Advanced Renal Cell Carcinoma Market Growth to Accelerate in Forecast Period (20 …
DelveInsight's "Advanced Renal Cell Carcinoma Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Antibody Drug Conjugates, historical and forecasted epidemiology…
Multiple Sclerosis Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials E …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Multiple Sclerosis pipeline constitutes 75+ key companies continuously working towards developing 80+ Multiple Sclerosis…
CTLA-4 Inhibitors Competitive Landscape and Clinical Trials Assessment 2025: FDA …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, CTLA-4 Inhibitors Competitive Landscape constitutes 40+ key companies continuously working towards developing 50+ CTLA-4…
Type 2 Diabetes Pipeline 2025: Therapies Under Investigation, Clinical Trials Mi …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Type 2 Diabetes pipeline constitutes 75+ key companies continuously working towards developing 80+ Type…
Relapsed/Refractory Acute Myeloid Leukemia Pipeline 2025: Therapies Under Invest …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Relapsed/Refractory Acute Myeloid Leukemia pipeline constitutes 50+ key companies continuously working towards developing 75+…
Dry Eye Disease Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Dry Eye Disease pipeline constitutes 50+ key companies continuously working towards developing 60+ Dry…
Waldenstrom Macroglobulinemia Treatment Market 2034: Clinical Trials, EMA, PDMA, …
(Albany, USA) DelveInsight's "Waldenstrom Macroglobulinemia Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Waldenstrom Macroglobulinemia, historical and forecasted epidemiology as…
Uveal Neoplasms Treatment Market 2032: Clinical Trials, EMA, PDMA, FDA Approvals …
(Albany, USA) DelveInsight's "Uveal Neoplasms Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Uveal Neoplasms, historical and forecasted epidemiology as…
Tumor-Infiltrating Lymphocytes Treatment Market 2032: Clinical Trials, EMA, PDMA …
(Albany, USA) DelveInsight's "Tumor-Infiltrating Lymphocytes Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Tumor-Infiltrating Lymphocytes, historical and forecasted epidemiology as…
TRK Fusion Cancer Treatment Market 2032: Clinical Trials, EMA, PDMA, FDA Approva …
(Albany, USA) DelveInsight's "TRK Fusion Cancer Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the TRK Fusion Cancer, historical and forecasted…
Urticaria Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key C …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Urticaria pipeline constitutes 20+ key companies continuously working towards developing 25+ Urticaria treatment therapies,…
Neurofibromatosis Type 2 Pipeline 2025: MOA and ROA Insights, Clinical Trials St …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Neurofibromatosis Type 2 pipeline constitutes 5+ key companies continuously working towards developing 5+ Neurofibromatosis…
Go To Page: 1 2 3 4 5 6 7 8 9 10 61 62 63 64 65 66 67 68 69 70
